High-risk soft tissue sarcoma: Clinical trial and hyperthermia combined chemotherapy

International Journal of Hyperthermia

Volumn 22, Issue 3, 2006, Pages 235-239

  Issels, Rolf D ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Hyperthermia; Soft tissue sarcomas; Thermochemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RISK; CANCER SURVIVAL; CHEMOSENSITIVITY; CLINICAL TRIAL; CONFERENCE PAPER; EXTERNAL BEAM RADIOTHERAPY; HEATING; HIGH RISK PATIENT; HUMAN; HYPERTHERMIC THERAPY; MULTIMODALITY CANCER THERAPY; RISK ASSESSMENT; SOFT TISSUE SARCOMA; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; SARCOMA; SURVIVAL ANALYSIS;

EID: 33745064864     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730600707793     Document Type: Conference Paper

References (14)

1. Kattan, MW and Leung, DH and Brennan, MF. (2002) Postoperative nomogram for 12-year sarcoma-specific death J Clin Oncol, 20, pp. 791-796.
2. Pisters, PW and Leung, DH and Woodruff, J and Shi, W and Brennan, MF. (1996) Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities J Clin Oncol, 14, pp. 1679-1689.
3. Stoeckle, E and Coindre, JM and Bonvalot, S and Kantor, G and Terrier, P and Bonichon, F and Nguyen, BB and and the French Federation of Cancer Centers Sarcoma Group. (2001) Prognostic factors in retroperitoneal sarcoma: A multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group Cancer, 92, pp. 359-368.
4. Eggermont, AM and de Wilt, JH and Ten Hagen, TL. (2003) Current uses of isolated limb perfusion in the clinic and a model system for new strategies Lancet Oncol, 4, pp. 429-437.
5. Gortzak, E and Azzarelli, A and Buesa, J and Bramwell, VH and van Coer Orden, F and van Geel, AN and Ezzat, A and Santoro, A and Oosterhuis, JW and van Glabbeke, M and Kirkpatrick, A and Verweij, J and EORTC Soft Tissue and Bone Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group/Canadian Sarcoma Group. (2001) A randomised Phase II study on neoadjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma Eur J Cancer, 37, pp. 1096-1103.
6. Delaney, TF and Spiro, IJ and Suit, HD and Gebhardt, MC and Hornicek, FJ and Mankin, HJ and Rosenberg, AL and Rosenthal, DI and Miryousefi, F and Ancukiewicz, M and Harmon, DC. (2003) Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas Int J Radiat Oncol Biol Phys, 56, pp. 1117-1127.
7. Wust, P and Hildebrandt, B and Sreenivasa, G and Rau, B and Gellermann, J and Riess, H and Felix, R and Schlag, PM. (2002) Hyperthermia in combined treatment of cancer Lancet Oncol, 3, pp. 487-497.
8. Issels, RD and Prenninger, SW and Nagele, A and Boehm, E and Sauer, H and Jauch, KW and Denecke, H and Berger, H and Peter, K and Wilmanns, W. (1991) Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: A phase II study J Clin Oncol, 8, pp. 1818-1829.
9. Issels, RD and Mittermueller, J and Gerl, A and Simon, W and Ortmaier, A and Denzlinger, C and Sauer, H and Wilmanns, W. (1991) Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: Updated report on 65 patients J Cancer Res Clin Oncol, 117(Suppl IV), pp. 141-147.
10. Issels, RD and Abdel-Rahman, S and Wendtner, CM and Falk, MH and Kurze, V and Sauer, H and Aydemir, U and Hiddemann, W. (2001) Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk soft tissue sarcomas (HR-STS) of adults: Long-term results of a phase II study Eur J Cancer, 37, pp. 1599-1608.
11. Wendtner, CM and Abdel-Rahman, S and Baumert, J and Falk, MH and Krych, M and Santl, M and Hiddemann, W and Issels, RD. (2001) Treatment of primary, recurrent or inadequately resected high-risk soft tissue sarcomas (HR-STS) of adults: Results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia Eur J Cancer, 37, pp. 1609-1616.
12. Wendtner, CM and Abdel-Rahman, S and Krych, M and Baumert, J and Lindner, LH and Baur, A and Hiddemann, W and Issels, RD. (2002) Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas J Clin Oncol, 20, pp. 3156-3164.
13. Lindner, LH and Schlemmer, M and Hohenberger, P and Wust, P and Abdel-Rahman, S and Schmidt, M and Judson, I and Blay, JY and Verweij, J.(). Issels RD for the EORTC STBSG and ESHO. First interim report on the randomized EORTC 62961/ESHO-RHT 95 Intergroup Study (Phase III) combined with regional hyperthermia (RHT) versus chemotherapy alone in the treatment of high-risk soft tissue sarcomas (HR-STS) in adults. In ASCO Annual Meeting 2004 [pp.]. (Abstract No. 9015)
14. Lindner, LH and Schlemmer, M and Hohenberger, P and Wust, P and Schmidt, M and Verweij, J and Judson, I and Jauch, KW and Hiddemann, W and Issels, RD.(). Risk assessment of early progression among 213 pts with high-risk soft tissue sarcomas (HR-STS) treated with neoadjuvant chemotherapy±regional hyperthermia: EORTC 62961/ESHO-RHT 95 intergroup phase III study. In ASCO Annual Meeting 2005 [pp.]. (Abstract No. 9020)